IOL Chemicals and Pharmaceuticals to limit capex at Rs 150 crore per year
The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business
The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
MTL, with over 40 years of experience in packaging, caters to the requirements of the FMCG, F&B, homecare, personal care, agrochemicals, pharmaceutical, and liquor industries
The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.
Subscribe To Our Newsletter & Stay Updated